LANZAJET – AN EARLY MOVER IN AUSTRALIA – APPLAUDS THE AUSTRALIAN GOVERNMENT’S LEADERSHIP AND GAME-CHANGING $1.1B (AUD) INVESTMENT TO ADVANCE SUSTAINABLE FUELS
LanzaJet's Alcohol-to-Jet technology for sustainable fuel production is key to enabling the…
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA)…
